Anthropic details drug work with six partners and acquires Mithril
Anthropic has announced deep research partnerships with six organizations to accelerate drug development, including BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group. The company stated that its scientists have been working with these partners for several months to integrate Claude into various stages of the drug creation process, from…
Key points
- Anthropic partnered with six organizations including Bristol Myers Squibb and Enveda to integrate Claude into drug development.
- Anthropic acquired Mithril Medicine, a one-person company working on muscular dystrophy treatments using Claude.
- Enveda reported Claude reduced document review time by 89%, cutting it from over 25 hours to less than three.
In addition to these collaborations, Anthropic acquired Mithril Medicine, a one-person company founded by Cody Tranbarger. Mithril used Claude to manage operations and experiments with 11 external labs, taking a potential treatment for muscular dystrophy from concept to promising mouse results in under 18 months. Anthropic expects a drug candidate to be ready for human clinical trials as soon as late 2028 if current results hold.
The company shared specific case studies showing Claude's impact. For example, at Enveda, Claude reduced human review time for manufacturing documents by 89%, cutting the process from over 25 hours to less than three. At Generate Biomedicines, a design proposed by Claude Code was 70% shorter than the standard version and proved more effective in lab tests. Anthropic emphasized that this work is still largely preclinical and aims to identify bottlenecks across the entire drug development pipeline.
Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy
anthropic.com · 27 October 2026
Loading the full article…
This text was published by anthropic.com and written by Anthropic. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
Coverage and discussion
2sources- Hacker News discussion · 39 pointsnews.ycombinator.com
- Anthropic Reports Early Drug Development Progress With ClaudePress · Unite.AI ·
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Business & Funding
All →- Nvidia invests $3 billion in Meta as part of its stock offering · 13 src
- Verizon exec Prabha Jha co-writes 'The AI Anthology' after MIT senior AI program · 1 src
- Microsoft offers voluntary buyouts to about 60,000 workers in US, Canada, India, and UK · 35 src
- Physical Intelligence in talks to raise $1B+ led by Avenir and Lux Capital · 1 src
- Meta’s $25B share sale draws fivefold demand for AI funding · 1 src
Comments
via GitHub Discussions